Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Dr Reddy s Laboratories

Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment

Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment

Read More

Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter

Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter

Read More

Dr Reddy's Labs In Licensing Pact With Gilead Sciences For Remdesivir

Gilead Sciences has signed similar non-exclusive voluntary licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila.

Read More

Dr Reddy's Q4 Profit Jumps 76% To Rs 764 Crore On Higher Sales In US, Europe

The company reported a revenue of Rs 4,432 crore, up 10 per cent from the year-ago period.

Read More

Dr Reddy's Q2 Profit Doubles To Rs 1,093 Crore

"I am pleased with our performance across the businesses and strong cash generation during the quarter," said Co-Chairman and Managing Director G V Prasad.

Read More

Dr Reddy's Q1 Profit Slumps On Pricing Pressures In US

Export-driven Indian drugmakers have been working on making high-value complex generics to offset growing competition in the United States

Read More

Amazing Opportunities For Start-Ups In Health Care: GV Prasad

He said patients' treatment, hospitals and pharmaceuticals are some of the factors that would drive the growth of start-ups in the health care sector

Read More

Dr Reddy's Profit Misses View As Emerging Markets Sales Fall

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a quarterly profit that was below analysts' estimates due to a drop in sales, mainly in emerging markets

Read More

Dr Reddy's Labs Q1 Profit Slumps 75%, Misses Estimates

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, said its quarterly profit slumped 75 per cent, hurt by fierce competition in its largest market, the United States

Read More